1.	Phase III Randomized Study of Cisplatin-Based Trans-Arterial Chemoembolization Versus Hepatic Intra-Arterial Yttrium Y 90 Glass Microspheres (TheraSphere®) in Patients With Unresectable Advanced Hepatocellular Carcinoma Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: PCI-04128, PCI-IRB-0501021, NCT00109954
2.	Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: Sir-Spheres1, NCT00199173
3.	Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CTCT 06-11, NCT00493883
4.	Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: NMRC - AHCC05, NCT00712790
5.	Phase II Study of Selective Internal Radiotherapy With Yttrium Y 90 Microspheres, Selective External Radiotherapy With Tomotherapy, and Fluorouracil in Patients With Unresectable, Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases Phase: Phase II Type: Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: CCCGHS-SIRT-SERT, NCT00436267
6.	TheraSphere for the Treatment of Liver Metastases Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: G040148, NCT00511862
7.	Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 06057, P30CA033572, CHNMC-06057, CDR0000579146, NCI-2010-00429, NCT00589030
8.	Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma Phase: Phase II Type: Treatment Status: Completed Age: 18 to 80 Sponsor: Other Protocol IDs: INT 30/90, NCT00910572
9.	Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: UCSF-SIRT-Metastases, NCT01290536
10.	Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 07Q1, P30CA060553, NU-IRB-STU00002799, NCT00739167